Make your money go further for just 25p per day

Eden Research (AIM: EDEN) – exciting and long overdue developments

27/05/2015 · Eden Research PLC (EDEN) 

Eden Research is the AIM listed developer of natural solutions to agricultural, medical and industrial problems. At present, the primary focus of the Group is in the innovative use of terpenes, a naturally occurring compound, to create an exciting array of low-risk agricultural chemicals.

Yesterday the Group announced that it has received authorisation of its first product, 3AEY, for use in the prevention and treatment of botrytis (commonly known as bunch rot in viticulture) in table and wine grapes from the Regulatory Affairs Directorate in Malta. This is extremely welcome and long overdue news for the company which was incorporated in 1996 and has been actively pursuing authorisation to sell 3AEY for nearly eight years.

Eden Research has…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Eden Research PLC

Eden Research (AIM: EDEN) – exciting and long overdue developments

27/05/2015 · Company Insights
Eden Research is the AIM listed developer of natural solutions to agricultural, medical and industrial problems.…

IP has wide range of applications

15/01/2013 · Company Insights
Eden Research is an intellectual property company with two patented encapsulation delivery systems as its core…

More Company Insights

Rocketing share price

Stonking Small Cap: still on the fast track!

24/04/2024

Poorly worded | Sector winner | Improving returns

Sign-up to our free email updates

SIGN UP